CBD suppliers in the UK, forbidden by law to make medical claims, are relying on their customers learning about health benefits from other sources.

To stay within the UK law that prohibits any claims that they are beneficial for health, CBD products are usually sold as food supplements. Although consumers are undoubtedly in many cases purchasing the products for health reasons, not openly claiming these benefits allows brands to comply with Food Standards Agency (FSA) guidelines.

Nevertheless, many companies are finding their own way to make the regulations work for them and the consumer.

Overall there has been a move away from the cannabis-based branding that was common in the early days of the industry.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization